May 11, 2026

Semaglutide Linked to NAION Risk

A retrospective database study found a low absolute incidence but higher relative hazard of ischemic optic neuropathy following semaglutide initiation.

Conexiant

May 11, 2026

Stewardship Cuts Steroid Prescribing

Behaviorally informed peer comparison feedback was associated with a gradual decline in glucocorticoid prescribing

Conexiant

May 11, 2026

Ultrasound Attenuation Imaging Tracks Hepatic Steatosis

Attenuation imaging increased with visually graded steatosis severity in pediatric patients, but findings were not validated against MRI-PDFF or biopsy.

Conexiant

May 11, 2026

Remote Diet Support Studied in Diabetes

WhatsApp-based low-carbohydrate nutrition education was linked to short-term glycemic, weight, and medication-use improvements in a small primary care trial

Conexiant

May 11, 2026

Wearables May Boost T2D Mobility

Outpatient intervention combined physiotherapist counseling with wrist-worn activity monitoring.

Conexiant

May 11, 2026

Health, Social Needs Tied to Absences

National survey data suggest overlapping chronic health and social needs are associated with higher rates of illness-related missed school days among US children.

Conexiant

May 08, 2026

A Smarter Screen for Sleep Apnea Stimulation

A four-factor staging system stratified response rates from 90.9% to 37.5% in a retrospective cohort study, although the model showed only moderate discrimination (C statistic, 0.68) and requires external validation

Conexiant

May 08, 2026

Frontline Pharma: Sarah O’Keeffe

Ahead of HPLC 2026, Eli Lilly’s Sarah O’Keeffe reflects on leadership, collaboration, and the analytical advances helping bring increasingly complex medicines to patients

The Analytical Scientist

May 07, 2026

Tirzepatide's Surprising Skin Side Effect

A single case report described possible lichen planus pigmentosus inversus following tirzepatide initiation.

Conexiant

May 06, 2026

Obesity Not Associated With Worse Long-Term TAR Outcomes

A long-term cohort study found that obesity was not associated with worse patient-reported outcomes or higher reoperation rates following total ankle replacement in optimized surgical candidates.

Conexiant